Correction to: Nature Medicine https://doi.org/10.1038/s41591-023-02363-y, published online 15 May 2023.
In the version of this article initially published, the Acknowledgements did not include thanks to the Cancer Prevention and Research Institute of Texas (CPRIT) for support under grant no. RP180785. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Heczey, A., Xu, X., Courtney, A.N. et al. Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. Nat Med 30, 1210 (2024). https://doi.org/10.1038/s41591-024-02799-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-024-02799-w
